NASDAQ:UNCY | Cash Flow Statement | Unicycive Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.72M
2026-03-31-$12.82M-$6.24M$8,000.00-$5.16M$19.57M
2025-12-31-$14.67M-$8.03M$0.00-$12.07M$6.61M
2025-09-30-$6.01M
2025-06-30-$6.45M
2025-03-31$570,000.00-$8.9M$16,000.00-$16,000.00$2.55M
2024-12-31-$21.53M-$6.55M$22,000.00-$22,000.00$0.00$365,000.00
2024-09-30-$4.1M
2024-06-30$9.86M
2024-03-31-$20.96M-$6.46M$6,000.00-$6,000.00$45.69M
2023-12-31-$7.8M-$4.44M$0.00$0.00$0.00-$205,000.00
2023-09-30-$4.33M
2023-06-30-$3.84M
2023-03-31-$14.58M-$3.92M$200,000.00$27.8M
2022-12-31-$5.33M-$6.08M$0.00$0.00
2022-09-30-$5.56M
2022-06-30-$3.64M
2022-03-31-$3.54M-$2.96M$2,000.00-$2,000.00
2021-12-31-$2.75M-$1.4M$0.00
2021-09-30-$5.2M
2021-06-30-$1.1M
2021-03-31-$964,000.00-$673,000.00$820,000.00
2020-12-31-$880,000.00-$538,000.00$475,000.00
2020-09-30-$702,000.00
2020-06-30-$338,000.00
2020-03-31-$344,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$26.56M-$31.32M$24,000.00-$12.1M$46.47M
2024-12-31-$36.73M-$28.58M$72,000.00-$72,000.00$1.1M$45.09M
2023-12-31-$30.54M-$18.28M$12,000.00-$12,000.00$900,000.00$27.54M
2022-12-31-$18.06M$428,000.00-$15.65M$2,000.00-$2,000.00-$471,000.00
2021-12-31-$10.02M$468,000.00-$5.77M$29,000.00-$29,000.00$22.38M
2020-12-31-$2.26M-$1.46M$1.44M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.